Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEP1B | Q16820 | 2/20 | 0.49 |
| ▸ | PGK1 | P00558 | 4/20 | 0.47 |
| ▸ | PGK2 | P07205 | 4/20 | 0.47 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.44 |
| ▸ | ACP3 | P15309 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9445919 | 1.00 | MEP1B (0.49) | MEP1BPGK1PGK2CD274MEN1 | |
| SCHEMBL9445933 | 0.86 | MEP1B (0.51) | MEP1BPGK1PGK2MEN1KMT2A | |
| SCHEMBL9445938 | 0.86 | MEP1B (0.51) | MEP1BPGK1PGK2MEN1KMT2A | |
| SCHEMBL18475402 | 0.82 | MEP1B (0.54) | MEP1BCD274MEN1KMT2APDCD1 | |
| SCHEMBL6240677 | 0.79 | ALDH1A1 (0.54) | MEP1BCD274MEN1KMT2APDCD1 | |
| SCHEMBL28499340 | 0.79 | ACP3 (0.51) | MEP1BCD274MEN1KMT2AACP3 | |
| SCHEMBL497818 | 0.78 | SIGMAR1 (0.55) | MEP1BCD274MEN1KMT2A | |
| SCHEMBL3556483 | 0.78 | SIGMAR1 (0.55) | MEP1BCD274MEN1KMT2A | |
| SCHEMBL497817 | 0.78 | SIGMAR1 (0.55) | MEP1BCD274MEN1KMT2A | |
| SCHEMBL6237660 | 0.78 | MAOB (0.56) | MEP1BCD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5179085-A | Cerebrovascular disorders | WARNER-LAMBERT COMPANY (US) | 1993-01-12 | — | — | US | disclosed |